October 28, 2026 Bonus Content: CVX Owns a Piece of Eavor. Now It Should Buy the Rest. A note from…
Your book is inside
October 28, 2026 Bonus Content: Stellantis Revenue Grew in Q3. Europe Is Why. North America Is the Problem. A note…
Finally… options made simple
October 28, 2026 Bonus Content: Enphase Drops 16% After Missing on Revenue, Earnings, and Guidance A note from our friends…
The Next AI Shock Starts Here
October 28, 2026 Bonus Content: T-Mobile’s $1.17 Dividend Is on the Line Tonight A note from our friends at MarketWise(ad)…
Pfizer Got FDA Approval. The Stock Didn’t Care.
Pfizer had genuinely good clinical news on Monday. The FDA approved Talzenna (talazoparib) in combination with Xtandi (enzalutamide) on October…
Is Trump “taking America public”? Here’s how to own a piece.
October 27, 2026 Bonus Content: Royal Caribbean Beats EPS but Misses Revenue. Shares Drop 7%. A note from our friends…
The government calendar I keep on my desk
October 27, 2026 The strang government calendar I keep on my desk Bonus Content: S&P Global’s Subscription Problem Is the…
The KOSPI Just Tripped Its Second Halt in Six Days. That Is Not a Healthy Rally.
The Korea Exchange paused program buying for five minutes this morning, the second such halt in six days, after the…
Everything in your 401(k) is a promise
October 26, 2026 Bonus Content: FedEx Lost 667 Pilots. Its Autonomous Aircraft Partner Flew Without One. A note from our…
Use this link before it changes
October 26, 2026 Bonus Content: HON’s Armor Business Spun Out. The Defense Demand Didn’t. A note from our friends at…